What is Lantheus Holdings's 2027?

Lantheus Holdings (LNTH) reported 2027 of $782K in Q4 2025.

Lantheus Holdings LNTH 2027

2027 at other companies

ImmunityBio, Inc.IBRX

——

Bio-Rad LaboratoriesBIO

——

Other financials

Income statement

See full

Revenue$377.3M+1.2%

Gross profit$230.9M-2.9%

Operating income$81.3M-20.3%

Net income$118.4M+62.3%

EPS (diluted)$1.80+76.5%

Balance sheet

See full

Cash & equivalents$500.3M-46.8%

Total debt$627.9M+1.8%

Total equity$1.2B+4.1%

Total assets$2.3B+14.2%

Cash flow

See full

Operating cash flow$125.1M+16.3%

CapEx$3.2M-63.0%

Free cash flow$121.9M+23.3%

Valuation

See full

Market cap$6.76B-26.3%

Enterprise value$6.89B-20.5%

P/E24.2×-10.2×

P/S4.4×-1.6×

Profitability

See full

Gross margin60.5%-3.6pp

Operating margin18.8%-10.7pp

Net margin18%+0.7pp

FCF margin24.4%-6.4pp

Returns & leverage

See full

Return on equity23.5%-1.7pp

Debt / equity0.5×0.0×

Current ratio2.8×-2.9×

Where this comes from

Reported directly by Lantheus Holdings in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths.

The official record: Lantheus Holdings’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lantheus Holdings's 2027.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lantheus Holdings's 2027?: Lantheus Holdings (LNTH) reported 2027 of $782K in Q4 2025.